MGMT and glioblastoma: While alterations in DNA repair mechanisms, especially MGMT promoter methylation, are key factors in TMZ resistance in GBM [9, 28], combining MGMT inhibitors with TMZ has been challenging due to toxicity, drug interactions, and the presence of additional resistance mechanisms that may affect treatment outcomes [29–32].